Ypsomed Holding AG, Roche Holding AG, Novo Nordisk A/S, Eli Lilly & Co.

    Coupon p.a.: 9.50%  |  Issuercallable  |  Currency: CHF  |  Maturity: 09/11/2026

    %
    CHF Nominal

    %
    CHF Nominal

    Product Overview

    Key figures

    Bonus amount per interval
    2.37% (23.75 CHF)
    Call interval (in months)
    3
    Distance to Barrier
    33.38%

    Life Cycle

    • Initial Fixing
    • First trading day
    • Today
    • Last trading date
    • Final fixing
    • Redemption
    Product performance (1D):
    GraphUnderlyingPrice (indicative)Last Closing Price (indicative)Performance
    -Eli Lilly & Co.Price (indicative)
    Last Closing Price (indicative)826.4500 USDPerformance+1.48%
    -Novo Nordisk A/SPrice (indicative)
    Last Closing Price (indicative)593.4874 DKKPerformance+3.72%
    -Roche Holding AGPrice (indicative)
    Last Closing Price (indicative)285.0331 CHFPerformance+1.82%
    -Ypsomed Holding AGPrice (indicative)
    Last Closing Price (indicative)352.8525 CHFPerformance+1.36%

    Product Information

    About this product

    Like the classic version, Multi Callable Barrier Reverse Convertibles (BRCs) are characterized by a pre-determined coupon and a safety buffer up to the barriers. The callable attribute improves the yield because coupons are generally higher than for regular Multi BRCs, but investors bear the reinvestment risk if the products are redeemed ("called") early.